Ishares Vii Public Etf Profile
| CSTNL Etf | USD 641.00 6.86 1.08% |
Performance11 of 100
|
IShares VII is selling for 641.00 as of the 30th of November 2024. This is a 1.08 percent increase since the beginning of the trading day. The etf's lowest day price was 636.14. IShares VII has 50 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. Equity ratings for iShares VII Public are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
IShares Pink Sheet Highlights
| Average Daily Volume In Three Month | 9.97k |
| Average Daily Volume Last 10 Day | 23.94k |
iShares VII Public [CSTNL] is traded in USA and was established null. The fund is not filed under any group at this time. The fund currently have in assets under management (AUM).
Check IShares VII Probability Of Bankruptcy
iShares VII Public Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares VII. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Mean Deviation | 0.5687 | |||
| Semi Deviation | 0.6179 | |||
| Standard Deviation | 0.8335 | |||
| Variance | 0.6947 |
iShares VII Public Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. iShares VII Public Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe IShares VII price patterns.
IShares VII Against Markets
Other Information on Investing in IShares Pink Sheet
IShares VII financial ratios help investors to determine whether IShares Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IShares with respect to the benefits of owning IShares VII security.